Published in Elder Law Weekly, March 23rd, 2005
The study will follow 2,500 patients for 3-1/2 years to determine if pacemaker-detected AHRE (atrial high rate events) predict an increased risk of stroke in elderly hypertensive patients without previous atrial fibrillation (AF). ASSERT also examines the efficacy of St. Jude Medical's AF suppression algorithm in helping these patients avoid symptomatic AF.
Sinan Gursoy, MD, enrolled the first U.S. patient in the ASSERT study at Naples Community...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.